Rosiglitazone attenuates endothelin-1-induced vasoconstriction by upregulating endothelial expression of endothelin B receptor.
about
Metformin exaggerates phenylephrine-induced AMPK phosphorylation independent of CaMKKβ and attenuates contractile response in endothelium-denuded rat aorta.Rosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPARγ- and PPARδ-Dependent Phosphorylation of Akt and eNOS.Transforming growth factor beta 1 induced endothelin-1 release is peroxisome proliferator-activated receptor gamma dependent in A549 cellsShort-Term Therapy with Rosiglitazone, a PPAR-γ Agonist, Improves Metabolic Profile and Vascular Function in Nonobese Lean Wistar RatsOxidative stress-dependent cyclooxygenase-2-derived prostaglandin f(2α) impairs endothelial function in renovascular hypertensive rats.Rosiglitazone Attenuated Endothelin-1-Induced Vasoconstriction of Pulmonary Arteries in the Rat Model of Pulmonary Arterial Hypertension via Differential Regulation of ET-1 Receptors.Nitric oxide: orchestrator of endothelium-dependent responses.The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.Molecular mechanisms regulating vascular tone by peroxisome proliferator activated receptor gamma.Telmisartan prevents angiotensin II-induced endothelial dysfunction in rabbit aorta via activating HGF/Met system and PPARγ pathway.Telmisartan ameliorates vascular endothelial dysfunction in coronary slow flow phenomenon (CSFP).
P2860
Q34616393-23D18CA6-C422-40C7-A431-005F4F948E15Q35608658-C9A31545-6454-49C4-9FEA-EB821D183083Q36049930-2AA8C07D-67AA-4EBE-AE73-4A6B7C0D6B00Q36203979-036E37AB-C40D-4ECA-822A-EB64954F623AQ36645351-0CB5E1CA-E00E-4DF0-A28F-22DD017857EAQ37632333-62E68B5F-8AB1-4DCF-BE16-0A5B3D040985Q37927098-299D3DB1-3185-47CA-A851-28BBEABCF04BQ38273378-D35BE38F-27A3-4F4D-9FA3-3370796DD197Q38318147-A213F0B6-2021-410E-9753-321F8C6057D9Q43625461-9226FACE-7745-45A6-8E9A-D9A525A25FF2Q47219223-92AD881D-9060-4136-A262-C3947DF9516B
P2860
Rosiglitazone attenuates endothelin-1-induced vasoconstriction by upregulating endothelial expression of endothelin B receptor.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Rosiglitazone attenuates endot ...... sion of endothelin B receptor.
@en
Rosiglitazone attenuates endot ...... sion of endothelin B receptor.
@nl
type
label
Rosiglitazone attenuates endot ...... sion of endothelin B receptor.
@en
Rosiglitazone attenuates endot ...... sion of endothelin B receptor.
@nl
prefLabel
Rosiglitazone attenuates endot ...... sion of endothelin B receptor.
@en
Rosiglitazone attenuates endot ...... sion of endothelin B receptor.
@nl
P2093
P1433
P1476
Rosiglitazone attenuates endot ...... ssion of endothelin B receptor
@en
P2093
Jianwei Tian
Nanping Wang
Peng Zhang
Xiao Yu Tian
P304
P356
10.1161/HYPERTENSIONAHA.110.150375
P407
P577
2010-06-01T00:00:00Z